Mark Aguillard

Mark Aguillard

Corporate Officer/Principal presso DERMTECH, INC.

Patrimonio netto: 28 350 $ in data 31/05/2024

Health Technology
Consumer Services
Technology Services

Provenienza dei contatti di primo grado di Mark Aguillard

EntitàTipo di entitàSettore Industriale
Public Company Medical Specialties 18
1
Holding Company Medical Specialties 1
1
Holding Company Information Technology Services 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Mark Aguillard tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Medical Specialties

Cynthia Collins

Matthew Posard

Herm Rosenman

Burkhard Jansen

James Rock

Claudia Ibarra

Kevin Sun

Director/Board Member

Chairman

Director/Board Member

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Chief Operating Officer

Director of Finance/CFO

MYRIAD GENETICS, INC. Medical Specialties

Mark Capone

Bret Christensen

Loren Clarke

Steven Stone

Chief Executive Officer

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Medical Specialties

Kirk Malloy

Matthew Posard

Kevin Sun

Chief Tech/Sci/R&D Officer

Sales & Marketing

Corporate Officer/Principal

DEXCOM, INC. Medical Specialties

Kevin Sun

Rachel Williams

Director of Finance/CFO

Corporate Officer/Principal

Miscellaneous Commercial Services

David King

Mark Capone

Chairman

Director/Board Member

ORGANOVO HOLDINGS, INC. Biotechnology

Kirk Malloy

Steve Kunszabo

Chairman

Investor Relations Contact

Medical Specialties

Matthew Posard

Herm Rosenman

Sales & Marketing

Director of Finance/CFO

ILLUMINA, INC. Biotechnology

Kirk Malloy

Matthew Posard

Corporate Officer/Principal

Corporate Officer/Principal

VIVUS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Electronic Production Equipment

Herm Rosenman

Founder

MEDISTEM INC Medical Specialties

Herm Rosenman

Director/Board Member

OXFORD IMMUNOTEC GLOBAL PLC Medical Specialties

Herm Rosenman

Director/Board Member

NATERA, INC. Medical Specialties

Herm Rosenman

Director/Board Member

Investment Managers

Herm Rosenman

Chief Executive Officer

Medical/Nursing Services

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Medical Specialties

Herm Rosenman

Director/Board Member

Wireless Telecommunications

Steve Kunszabo

Investor Relations Contact

IRIDIUM COMMUNICATIONS INC. Specialty Telecommunications

Steve Kunszabo

Investor Relations Contact

The Wharton School of the University of Pennsylvania College/University

Herm Rosenman

Masters Business Admin

ARYX THERAPEUTICS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Ultra Acquisition Corp.

Herm Rosenman

Chief Executive Officer

TALIS BIOMEDICAL CORPORATION Medical Specialties

Matthew Posard

Director/Board Member

Panavance Therapeutics, Inc.

Cynthia Collins

Director/Board Member

Information Technology Services

Cynthia Collins

Director/Board Member

HALOZYME THERAPEUTICS, INC. Biotechnology

Matthew Posard

Director/Board Member

University of California San Diego College/University

Matthew Posard

Undergraduate Degree

CARDIFF ONCOLOGY, INC. Medical Specialties

Matthew Posard

Corporate Officer/Principal

Packaged Software

Matthew Posard

Director/Board Member

Packaged Software

Matthew Posard

President

Miscellaneous Commercial Services

Matthew Posard

Chairman

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Herm Rosenman

Director/Board Member

Miscellaneous Commercial Services

Matthew Posard

Director/Board Member

Information Technology Services

Matthew Posard

Chairman

NAUTILUS BIOTECHNOLOGY, INC. Biotechnology

Matthew Posard

Chairman

Explore DNA

Matthew Posard

Corporate Officer/Principal

Biotechnology

Matthew Posard

Director/Board Member

Packaged Software

Matthew Posard

Director/Board Member

Pace University College/University

Herm Rosenman

Undergraduate Degree

METACRINE, INC. Biotechnology

Steve Kunszabo

Investor Relations Contact

NIRI San Diego

Steve Kunszabo

Director/Board Member

University of Vienna College/University

Burkhard Jansen

Corporate Officer/Principal

Medical/Nursing Services

Burkhard Jansen

Chief Executive Officer

DERMIRA, INC. Pharmaceuticals: Major

Ray Bassi

Sales & Marketing

Statistiche

Distribuzione geografica

Stati Uniti 47
Regno Unito 3
Italia 2
Austria 2

Settori

Health Technology 25
Commercial Services 6
Technology Services 6
Consumer Services 5
Health Services 3

Posizioni

Director/Board Member 85
Corporate Officer/Principal 36
Independent Dir/Board Member 23
Chairman 18
Director of Finance/CFO 17